| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/04/2008 | WO2008106104A2 Environmentally sensitive fluorophores |
| 09/04/2008 | WO2008105759A1 Methods for synthesis of modified peptides |
| 09/04/2008 | WO2008105441A1 Poly(amino acid) compound having inhibitory activity on absorption of phosphorus and phosphorus absorption inhibitor |
| 09/04/2008 | WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | WO2008104090A1 Template-fixed peptidomimetics |
| 09/04/2008 | US20080214782 Amino acid sequence phosphorylation site motif; structural variance and disease diagnosis |
| 09/04/2008 | US20080214648 Hiv Prodrugs Cleavable by Cd26 |
| 09/04/2008 | US20080214478 Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways |
| 09/04/2008 | US20080214477 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 09/04/2008 | US20080214476 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 09/04/2008 | US20080214475 Small Peptides And Methods For Inhibiting The Mucous Release Into Airways |
| 09/04/2008 | US20080214474 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease |
| 09/04/2008 | US20080214473 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; treatment and prevention of respiratory system disorders; antiinflammatory agents; immunotherapy |
| 09/04/2008 | US20080214472 Small Peptides And Methods For Treatment Of Arthritis |
| 09/04/2008 | US20080214470 Pin1-Modulating Compounds and Methods of Use Thereof |
| 09/04/2008 | US20080214469 Novel Biologically Active Peptides and Their New Uses |
| 09/04/2008 | US20080214457 Isolated peptide, polynucleotide that encodes a peptide that is from 10 to 100 amino acids in length |
| 09/04/2008 | US20080214447 For treatment of hepatitis C |
| 09/04/2008 | US20080214411 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/04/2008 | US20080213898 Compositions and methods for nucleic acid delivery |
| 09/04/2008 | US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| 09/04/2008 | US20080213827 Process For Producing Dipeptides or Dipeptide Derivatives |
| 09/04/2008 | US20080213822 Methods for diagnosing celiac sprue and reagents useful therein |
| 09/04/2008 | US20080213818 Cellular immunity test with peptides attached to a solid support |
| 09/04/2008 | US20080213796 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity |
| 09/04/2008 | US20080213795 Plasmodium epitope polypeptide for use in treatment and prevention malarial infection |
| 09/04/2008 | US20080213311 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 09/04/2008 | US20080213271 Using dopamine receptor specific immunoglobulin to enhance dopaminergic neurotransmission and treat or prevention nervous system and/or neuropsyciatric disorders |
| 09/04/2008 | US20080213240 RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK |
| 09/04/2008 | US20080213176 Labelled peptide; an amino acid sequence of at least 7 amino acids, comprising a mid-part having a lysine residue, and terminal parts comprising consecutive glycine residues |
| 09/04/2008 | CA2679514A1 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | CA2679414A1 Template-fixed peptidomimetics |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1963364A2 Compounds and methods for inhibiting apoptosis |
| 09/03/2008 | EP1963357A1 Compounds for the inhibition of apoptosis |
| 09/03/2008 | EP1962870A2 Novel hydrogels and uses thereof |
| 09/03/2008 | EP1730170A4 Method for inhibiting immune complex formation in a subjetc |
| 09/03/2008 | EP1684788B1 Peptide increasing fusiogenic capacity of a gamete |
| 09/03/2008 | EP1292613B1 Chimeric GPF-Aequorin as bioluminiscent Ca++ reporters at the single cell level |
| 09/03/2008 | EP1098903B1 Method for preparing cyclosporin derivatives |
| 09/03/2008 | EP1036181B1 The process for expression and production of recombinant protein gp90 derived from glicoprotein envelope of equine infectious anemia virus eiav |
| 09/03/2008 | EP0804576B1 A novel haemopoietin receptor |
| 09/03/2008 | CN101257799A Composition for controlling common scab of agricultural crop containing surfactin |
| 09/03/2008 | CN101255190A Use of human midkine protein blocking peptide in preparation of antitumor medicament |
| 09/03/2008 | CN101255189A Animal vaccine immunopotentiator and production method thereof |
| 09/03/2008 | CN100415771C Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use |
| 09/02/2008 | US7420037 Heat shock protein-based vaccines and immunotherapies |
| 09/02/2008 | US7420034 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use in vaccines |
| 09/02/2008 | US7420031 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 09/02/2008 | US7420030 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 09/02/2008 | US7419952 Use of exendins and agonists thereof to treat diabetes |
| 09/02/2008 | CA2316052C Sustained release formulations of water soluble peptides |
| 08/28/2008 | WO2008033891A3 Azonafide derived tumor and cancer targeting compounds |
| 08/28/2008 | US20080207875 Oligopeptide of given sequence, modified by cyclic topology; prevent infections and immune deficiencies |
| 08/28/2008 | US20080207874 cyclopeptide intermediates are prepared from polymyxin B are used to synthesize new peptide antibiotics; readily derivatized and deprotected to provide new families of antibiotics, which have potent anti-bacterial activity against gram-negative bacteria; also are useful and potent against gram-positive |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207525 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents; bioavailability; coupling; chemical intermediates |
| 08/28/2008 | US20080207523 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 08/28/2008 | US20080207522 Antimicrobial Peptides |
| 08/28/2008 | US20080207521 Polypeptide encoding amino acid sequence including MDGCEL (formylated Met-Asp-Gly-Cys-Glu-Leu) hexapeptide; antitumor and antimetastatic agents for treatment of breast, colon, thyroid, and nervous system cancer; mimic effects of Wnt-5a protein; increased adhesion impairs cancer cell migration |
| 08/28/2008 | US20080207520 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080207502 Anti-Angiogenic Peptides and Methods of Use Thereof |
| 08/28/2008 | US20080206270 vaccines that rely on eliciting cellular immune responses, specifically induction of cytotoxic T lymphocytes (CTL), against cancer cells and virus-infected cells via administration of a vaccine comprising a fusion peptide or a modified peptide; derived from antigens PRAME, OFA/iLRP, STEAP and SURVIVIN |
| 08/28/2008 | US20080206268 HA-1 epitopes and uses thereof |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | US20080206218 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
| 08/28/2008 | US20080206217 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080206216 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
| 08/28/2008 | US20080206160 Antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and antiinflammatory properties; preventing and reversing skin surface damage; wound healing include abrasions, blisters, burns, lacerations, ulcers, bruises, rashes, scars, and the effects of aging |
| 08/28/2008 | US20080206136 Binding Peptidomimetics and Uses of the Same |
| 08/28/2008 | CA2678941A1 Triazole macrocycle systems |
| 08/27/2008 | EP1961761A1 Novel peptide compound |
| 08/27/2008 | EP1961760A2 Peptides and compounds that bind to a thrombopoietin receptor |
| 08/27/2008 | EP1960422A2 Potent compstatin analogs |
| 08/27/2008 | EP1960421A1 New polypeptides and their use |
| 08/27/2008 | EP1481059B1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 08/27/2008 | EP1156817B1 Controlling protein levels in eucaryotic organisms |
| 08/27/2008 | EP1115418B1 Diagnosis of cancers associated with viral infections using aglycoprotein 10B |
| 08/27/2008 | EP0826060B1 Embedded expression of heterologous proteins |
| 08/27/2008 | CN101250219A Short peptide series suppressing growth of leukemia cancer cell and uses thereof |
| 08/27/2008 | CN101249258A An uro-genital condition treatment system |
| 08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
| 08/27/2008 | CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 08/26/2008 | US7417112 Multiblock copolymers having improved mechanical properties |
| 08/26/2008 | US7417028 Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions |
| 08/26/2008 | US7417027 For decreasing food intake; eating disorders; sexual disorders |
| 08/26/2008 | US7417025 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions |
| 08/26/2008 | US7417024 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin |
| 08/26/2008 | CA2400007C Immunization of an individual against carcinoma and the preliminary stages thereof |
| 08/21/2008 | WO2008100482A2 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 08/21/2008 | WO2008100481A2 Lung cancer-targeted peptides and applications thereof |
| 08/21/2008 | WO2008099908A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | WO2008099561A1 Agent for promoting cell proliferation using antimicrobial peptide and method for promoting cell proliferation using serum-free medium containing the same |
| 08/21/2008 | WO2007101698A3 Modified molecules which promote hematopoiesis |
| 08/21/2008 | US20080200647 On-Resin Peptide Cyclization |
| 08/21/2008 | US20080200397 dextrorotatory amino acids; vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence; protect against amyloid-mediated neurotoxicity; have no similarities to the amino acid sequence in beta -amyloid regardless of the direction in which they are read |
| 08/21/2008 | US20080200396 Peptides or Peptidic Conjugate Derivatives of Msh and the Use Thereof for Cosmetically Fighting Against Canities |
| 08/21/2008 | US20080200393 Treat disease associated with substrate-phosphorylation by VEGF receptor, substrate-phosphorylation by PDGF receptor or substrate-phosphorylation by both VEGF and PDGF receptors |
| 08/21/2008 | US20080200392 Methods for Treating Parkinson's Disease |
| 08/21/2008 | US20080199934 Adding functional groups to peptides for use in preparation of muscle and silk protein |